TARS Operating Expenses
Tarsus Pharmaceuticals Inc · Operating Expenses
TARS Operating Expenses
Latest reported$597.84Mperiod ending
TARS TTM Operating Expenses ($1.02M → $597.84M)
TTM operating expenses
High-resolution chart · PNG
TARS operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 597,837,000 | |
| 534,737,000 | |
| 475,361,000 | |
| 412,547,000 | |
| 373,952,000 | |
| 326,456,000 | |
| 290,696,000 | |
| 261,103,000 | |
| 233,494,000 | |
| 194,888,000 | |
| 158,441,000 | |
| 126,792,000 | |
| 107,058,000 | |
| 94,532,000 | |
| 87,362,000 | |
| 77,511,000 | |
| 71,696,000 | |
| 65,715,000 | |
| 67,109,000 | |
| 63,776,000 | |
| 57,037,000 | |
| 46,302,000 | |
| 26,999,000 | |
| 16,606,000 | |
| 7,078,000 | |
| 3,477,500 | |
| 1,022,000 |